top of page

Join the Visionary Team

Shape the future of eye care with Kait Pharma. We offer growth, excellence, and a commitment to Kerala's health.

Visionary Eye Care Solutions

Premium pharmaceutical distribution excellence serving ophthalmologists and eye-care institutions across Kerala.

Pharmacological Portfolio – Precision-Engineered Ophthalmic Solutions

Kaitears eye drops at top ophthalmic pharma companies

KAIT Pharma is an emerging pharmaceutical company in Kerala focused on ophthalmic healthcare, committed to delivering quality eye-care products through a reliable distribution and professional healthcare network. With a focus on innovation, quality, accessibility, and customer trust, KAIT Pharma aims to become one of Kerala’s leading names in ophthalmic pharmaceuticals.

KAIT PHARMA DISTRIBUTION PVT LTD is a premier ophthalmic pharmaceutical company based in the heart of Kerala, India. We are dedicated to delivering visionary eye-care solutions that meet the highest standards of medical excellence and innovation.

Serving a vast network of ophthalmologists and specialized eye-care institutions, we provide a comprehensive portfolio of high-quality products. Our commitment to reliability and compliance ensures that healthcare professionals have the tools they need for superior patient outcomes.

Advanced Ocular Lubricants

KAITEARS eye drops packshot on white background, medical blue and green accents, portrait pack image
KAITEARS GEL eye gel packshot on white background, medical blue and purple accents, portrait pack image

KAITEARS

Composition: Carboxymethylcellulose Sodium USP 0.5% w/v
Indication: Keratoconjunctivitis Sicca treatment
Physiological formulation stabilized to provide rapid stabilization of the tear film and relief of ocular hyperosmolarity.
Therapeutic Benefit: Restores osmotic balance and protects corneal epithelium.
Patient Profile: Management of evaporative and aqueous-deficient dry eye.

Composition: Carboxymethylcellulose Sodium USP 1.0% w/v
Indication: Severe Dry Eye & Post-Surgical Recovery
High-viscosity polymer matrix engineered for prolonged residence time and sustained ocular surface hydration.
Therapeutic Benefit: Enhanced mucoadhesion providing long-lasting epithelial protection.
Patient Profile: Intensive therapy for persistent chronic ocular surface disorders.

KAITEARS GEL

KAITLUBE

Composition: Polyethylene Glycol 400 0.4%, Propylene Glycol 0.3%
Indication: Multi-Action Ocular Surface Restoration
Dual-polymer synergistic system designed for immediate symptomatic relief and long-term corneal repair.
Therapeutic Benefit: Intelligent delivery system that adapts to ocular pH for optimal lubrication.
Patient Profile: Comprehensive relief for moderate ocular irritation.

KAITMOIST

Kait Pharma Distribution sets industry standards through meticulous manufacturing and rigorous clinical validation, ensuring pharmaceutical integrity.

KAITPAT

Composition: Olopatadine Hydrochloride USP 0.2% w/v
Indication: Seasonal Allergic Conjunctivitis
Highly selective H1-receptor antagonist and mast cell stabilizer for rapid and sustained suppression of ocular allergies.
Therapeutic Benefit: Rapid onset of action for itching and hyperemia reduction.
Patient Profile: Management of acute and chronic allergic ocular manifestations.

Broad-Spectrum Anti-Infectives
KAITMOX

Composition: Moxifloxacin Hydrochloride USP 0.5% w/v
Indication: Bacterial Conjunctivitis & Prophylaxis
Fourth-generation fluoroquinolone specializing in the eradication of Gram-positive and Gram-negative pathogens.
Therapeutic Benefit: Superior tissue penetration and rapid bactericidal activity.
Clinical Use: Pre- and post-operative protection and infectious management.

Synergistic Anti-Inflammatory Combinations
KAITMOX-LP

Composition: Moxifloxacin HCl 0.5% & Loteprednol Etabonate 0.5% w/v
Indication: Steroid-Responsive Inflammatory Conditions
High-efficacy suspension providing targeted anti-infective coverage combined with site-specific corticosteroid action.
Clinical Benefit: Minimizes intraocular pressure spikes while maximizing inflammatory control.
Patient Profile: Steroid-sensitive patients requiring infection prophylaxis.

KAITMOX-DM

Composition: Moxifloxacin HCl 0.5% & Dexamethasone Sodium Phosphate 0.1% w/v
Indication: Intensive Post-Ocular Surgery Management
Potent combination designed for high-risk surgical cases requiring aggressive infection and inflammation prevention.
Clinical Benefit: Rapid suppression of post-operative edema and potent antimicrobial shielding.
Clinical Use: Gold-standard recovery for major ophthalmic procedures.

Ophthalmology-Focused Expertise

Deep clinical understanding of ophthalmic pharmaceutical needs and surgical requirements.

Quality & Compliance

Strict adherence to international pharmaceutical standards and cold-chain integrity protocols.

Reliable Distribution

Fast, localized distribution network serving institutions across Kerala with precision timing.

Complete Eye-Care Portfolio

A diverse range of ophthalmic solutions from lubricants to specialized anti-infectives.

Contact & Partnerships

We invite ophthalmologists and healthcare institutions to connect for visionary partnerships in eye care. Based in the heart of Kerala, we are committed to excellence in distribution.

Location

15/354 F, Valluvally Vazhuvelil Complex, Koonammavu, Paravur, Ernakulam, Kerala – 683518, India

Direct Connect

kaitpharma@gmail.com
+91 8714490346

Kait-Pharma-Distribution-Pvt-Ltd-logo
bottom of page